CD276 and medulloblastoma: Majzner et al (12) discovered that B7-H3 CAR T cells exhibited significant antitumor activity in vivo, leading to the regression of established solid tumors in xenograft models, including osteosarcoma, medulloblastoma, and Ewing sarcoma.